Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients
|ClinicalTrials.gov Identifier: NCT01497548|
Recruitment Status : Unknown
Verified December 2011 by Dr Ng Chong Guan, University of Malaya.
Recruitment status was: Recruiting
First Posted : December 22, 2011
Last Update Posted : December 22, 2011
University of Malaya
Information provided by (Responsible Party):
Dr Ng Chong Guan, University of Malaya
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||September 2012|
|Estimated Study Completion Date :||October 2012|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Ng CG, Boks MP, Roes KC, Zainal NZ, Sulaiman AH, Tan SB, de Wit NJ. Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study. Eur Neuropsychopharmacol. 2014 Apr;24(4):491-8. doi: 10.1016/j.euroneuro.2014.01.016. Epub 2014 Jan 20.